LAMA2 and respiratory tract infectious disorder: In total, 58.9% (63/107) of LAMA2-CMD and 35.7% (5/14) of LGMDR23 patients had a history of recurrent respiratory infection, mainly at ages of 0–3 years and 6–15 years (Fig. 1f).